Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Series Title
      Series Title
      Clear All
      Series Title
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Content Type
    • Item Type
    • Is Full-Text Available
    • Subject
    • Country Of Publication
    • Publisher
    • Source
    • Target Audience
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
391,095 result(s) for "Clinical psychology"
Sort by:
Clinical psychology : a very short introduction
Clinical psychology' makes a significant contribution to mental health care across the world. The essence of the discipline is the creative application of the knowledge base of psychology to the unique, personal experiences of individuals who are facing difficulties or changes in their lives. Rather than addressing such experiences as primarily a medical, political or legal problem, clinical psychologists approach personal distress as an unhappy outcome of certain ways of thinking, behaving and relating, often occurring within difficult social, cultural or economic circumstances. Clinical psychologists work with people to try and help them change what is distressing or concerning them, based on a belief in the value of the individual to determine what happens to them and on the importance of using approaches which have been demonstrated through research to be effective. In this Very Short Introduction, Susan Llewellyn and Katie Aafjes-van Doorn provide insights into the world of clinical psychologists and their clients or patients, and cover the range of domains of practice, the difficulties tackled, and the approaches and models used. They consider the challenges and controversies facing the profession today, and also how it varies across the globe.
Development and Validation of a Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16
The Difficulties in Emotion Regulation Scale (DERS) is a widely-used, theoretically-driven, and psychometrically-sound self-report measure of emotion regulation difficulties. However, at 36-items, the DERS may be challenging to administer in some situations or settings (e.g., in the course of patient care or large-scale epidemiological studies). Consequently, there is a need for a briefer version of the DERS. The goal of the present studies was to develop and evaluate a 16-item version of the DERS – the DERS-16. The reliability and validity of the DERS-16 were examined in a clinical sample (N = 96) and two large community samples (Ns = 102 and 482). The validity of the DERS-16 was evaluated comparing the relative strength of the association of the two versions of the DERS with measures of emotion regulation and related constructs, psychopathology, and clinically-relevant behaviors theorized to stem from emotion regulation deficits. Results demonstrate that the DERS-16 has retained excellent internal consistency, good test-retest reliability, and good convergent and discriminant validity. Further, the DERS-16 showed minimal differences in its convergent and discriminant validity with relevant measures when compared to the original DERS. In conclusion, the DERS-16 offers a valid and brief method for the assessment of overall emotion regulation difficulties.
Caregiving in the illness context
How does caregiving affect health and well-being and what resources help caregivers? This book provides a synthesis of psychological research on caregiver stress and brings attention to the personal, social and structural factors that affect caregivers' well-being and as well as recent behavioral interventions to enhance health.
The Routledge handbook of attachment : assessment
\"The Routledge Handbook of Attachment: Assessment provides, in one volume, a detailed discussion of the formal measurement tools available to assess attachment across the age range, including with families. It contains comprehensive chapters on many attachment-based validated procedures for assessing parenting and evaluating risk, to enable professionals to decide what type of assessment is appropriate, who should conduct it and the usefulness of the results. The book provides a detailed account of assessment measures of attachment to enable practitioners at all levels (including academic research workers) to decide which assessment procedure will best meet their need. The chapters are written by those who developed these tools and by people closely associated with them, and advocate an evidence-based model of assessment to increase fairness and transparency for families.Providing a practical guide to the uses of attachment theory and research in professional practice with adults, children, parents and families, and a detailed account of all the current evidence-based tools that can be used in assessment, The Routledge Handbook of Attachment: Assessment is ideal for professionals and clinicians wishing to commission or undertake assessments of attachment, as well as academic research workers and students. \"-- Provided by publisher.
Inscription, diagnosis, deception and the mental health industry : how Psy governs us all
\"Do you ever wonder how psychology came to dominate everything from the sports pages in daily newspapers to the language we use to describe ourselves? This historical analysis by one of the UK's leading critical psychologists answers that question by exploring the history of the harm caused by the Psy professions, the complicity of governments in the expansion of the psychology, psychiatric and pharmaceutical industries, and some ways of resisting that expansion. From incarceration to lobotomy, ECT to psychotherapy and diagnosis to death-making, the Psy industry continues to govern us all. This scholarly critique shows how\"-- Provided by publisher.
Posttraumatic stress disorder in the World Mental Health Surveys
Traumatic events are common globally; however, comprehensive population-based cross-national data on the epidemiology of posttraumatic stress disorder (PTSD), the paradigmatic trauma-related mental disorder, are lacking. Data were analyzed from 26 population surveys in the World Health Organization World Mental Health Surveys. A total of 71 083 respondents ages 18+ participated. The Composite International Diagnostic Interview assessed exposure to traumatic events as well as 30-day, 12-month, and lifetime PTSD. Respondents were also assessed for treatment in the 12 months preceding the survey. Age of onset distributions were examined by country income level. Associations of PTSD were examined with country income, world region, and respondent demographics. The cross-national lifetime prevalence of PTSD was 3.9% in the total sample and 5.6% among the trauma exposed. Half of respondents with PTSD reported persistent symptoms. Treatment seeking in high-income countries (53.5%) was roughly double that in low-lower middle income (22.8%) and upper-middle income (28.7%) countries. Social disadvantage, including younger age, female sex, being unmarried, being less educated, having lower household income, and being unemployed, was associated with increased risk of lifetime PTSD among the trauma exposed. PTSD is prevalent cross-nationally, with half of all global cases being persistent. Only half of those with severe PTSD report receiving any treatment and only a minority receive specialty mental health care. Striking disparities in PTSD treatment exist by country income level. Increasing access to effective treatment, especially in low- and middle-income countries, remains critical for reducing the population burden of PTSD.
Three randomized controlled trials evaluating the impact of “spin” in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit
Background News stories represent an important source of information. We aimed to evaluate the impact of “spin” (i.e., misrepresentation of study results) in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit. Methods We conducted three two-arm, parallel-group, Internet-based randomized trials (RCTs) comparing the interpretation of news stories reported with or without spin. Each RCT considered news stories reporting a different type of study: (1) pre-clinical study, (2) phase I/II non-RCT, and (3) phase III/IV RCT. For each type of study, we identified news stories reported with spin that had earned mention in the press. Two versions of the news stories were used: the version with spin and a version rewritten without spin. Participants were patients/caregivers involved in Inspire, a large online community of more than one million patients/caregivers. The primary outcome was participants’ interpretation assessed by one specific question “What do you think is the probability that ‘treatment X’ would be beneficial to patients?” (scale, 0 [very unlikely] to 10 [very likely]). Results For each RCT, 300 participants were randomly assigned to assess a news story with spin ( n  = 150) or without spin ( n  = 150), and 900 participants assessed a news story. Participants were more likely to consider that the treatment would be beneficial to patients when the news story was reported with spin. The mean (SD) score for the primary outcome for abstracts reported with and without spin for pre-clinical studies was 7.5 (2.2) versus 5.8 (2.8) (mean difference [95% CI] 1.7 [1.0–2.3], p  < 0.001); for phase I/II non-randomized trials, 7.6 (2.2) versus 5.8 (2.7) (mean difference 1.8 [1.0–2.5], p  < 0.001); and for phase III/IV RCTs, 7.2 (2.3) versus 4.9 (2.8) (mean difference 2.3 [1.4–3.2], p  < 0.001). Conclusions Spin in health news stories reporting studies of pharmacologic treatments affects patients’/caregivers’ interpretation. Trial registration ClinicalTrials.gov, NCT03094078 , NCT03094104 , NCT03095586